Safety And Efficacy Of Gvd And Anti-Pd-1 (Shr-1210) Regimen With Or Without Low-Dose Decitabine Priming For Refractory Bulky And Aggressive Primary Mediastinal Large B-Cell Lymphoma.
JOURNAL OF CLINICAL ONCOLOGY（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要